secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2024-08-22T23:59:59+00:00
Accession:  0001640334-24-001346
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience enters $20M at-the-market equity sales agreement with JonesTrading
--------------------------------------------------------------------------------

- Up to $20M of common stock may be sold from time to time through Agent JonesTrading as ATM offering.
- Agent will receive 3.0% commission on gross sales price; Company reimburses certain expenses.
- Shares sold under previously effective shelf registration statement (File No. 333-262402).
- Agreement terminates upon sale of all Shares or earlier termination by either party.
- No assurance any Shares will be issued; proceeds used for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424001346/0001640334-24-001346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424001346/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-24-001346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer